Search Within

Shanu Modi

  1. "Ayca Gucalp"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (3)
Groups
  1. Breast Medicine Service (14)
  2. Department of Medicine (14)
  3. Solid Tumor Oncology Division (14)
  4. Survivorship Research (14)
  5. Epidemiology and Biostatistics (12)
  6. Population Sciences Research Program (12)

More Groups

People
  1. Ayca Gucalp (14)
  2. Tiffany Traina (14)
  3. Chau Dang (9)
  4. Diana Lake (8)
  5. Neil Iyengar (8)
  6. Tiffany Troso-Sandoval (8)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Research (3)
  3. Annals of Oncology (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Breast Cancer Research and Treatment (1)
  6. European Heart Journal (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (3)
  3. Oxford University Press (3)
  4. Elsevier Inc. (2)
  5. American Medical Association (1)
  6. Springer (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save